Got only 12 minutes left.
He is the voice for hedge funds that shorting ACAD.
How soon can we learn if Nuplazid is approved or not.
Just plain dead money on SPPI. There are better pharma out there with better potential.
ALDR is up today by $8 on phase II trials for migraine drug. IGXT's migraine drug is already approve in Europe. When is IGXT going to double up in price.
ALDR is up today $10. for a Phase II migraine drug. why is IGXT in the cellar if they already have an approved migraine drug.